NCT00377091View on ClinicalTrials.gov

Is Using Fondaparinux (Blood Thinner) to Treat Lung Clot Cheaper Than Traditional Therapy

PHASE4WithdrawnINTERVENTIONAL

0

Timeline

Start Date

June 30, 2007

Primary Completion Date

November 30, 2007

Study Completion Date

November 30, 2007

Conditions

Pulmonary Embolism

Interventions

DRUG

Fondaparinux

Trial Locations (1)

55805

St. Mary's Medical Center, Duluth

Sponsors

Collaborators (1)

GlaxoSmithKline

All Listed Sponsors

collaborator

GlaxoSmithKline

INDUSTRY

lead

University of Minnesota

OTHER